Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
6.10. rezultāts no 100.
55. lappuse
... potassium Aluminum chlorhydroxy complex Aromatics Benzalkonium chloride Benzethonium chloride Benzocaine Benzoic acid Boric acid Calcium acetate Camphor gum Clove oil Colloidal oatmeal Cresol Cupric sulfate Eucalyptus oil Eugenol Ferric ...
... potassium Aluminum chlorhydroxy complex Aromatics Benzalkonium chloride Benzethonium chloride Benzocaine Benzoic acid Boric acid Calcium acetate Camphor gum Clove oil Colloidal oatmeal Cresol Cupric sulfate Eucalyptus oil Eugenol Ferric ...
56. lappuse
... potassium extract Caffeine Caffeine citrate Calcium Calcium carbonate Calcium caseinate Calcium lactate Calcium pantothenate Carboxymethylcellulose sodium Carrageenan Cholecalcierol Choline Chondrus Citric acid Cnicus benedictus Copper ...
... potassium extract Caffeine Caffeine citrate Calcium Calcium carbonate Calcium caseinate Calcium lactate Calcium pantothenate Carboxymethylcellulose sodium Carrageenan Cholecalcierol Choline Chondrus Citric acid Cnicus benedictus Copper ...
224. lappuse
... Potassium - containing active in- gredients : ( 1 ) Potassium bicarbonate ( or carbon- ate when used as a component of an ef- fervescent preparation ) ; maximum daily dosage limit 200 mEq . of bicar- bonate ion for persons up to 60 ...
... Potassium - containing active in- gredients : ( 1 ) Potassium bicarbonate ( or carbon- ate when used as a component of an ef- fervescent preparation ) ; maximum daily dosage limit 200 mEq . of bicar- bonate ion for persons up to 60 ...
361. lappuse
... potassium phosphate : 2.0 gm . Monobasic potassium phosphate : 8.0 gm . Distilled water , q.s : 1,000.0 ml . Adjust with 18N phosphoric acid or 10N potassium hydroxide to yield a pH 5.95 to 6.05 after sterilization . ( 2 ) Solution 2 ...
... potassium phosphate : 2.0 gm . Monobasic potassium phosphate : 8.0 gm . Distilled water , q.s : 1,000.0 ml . Adjust with 18N phosphoric acid or 10N potassium hydroxide to yield a pH 5.95 to 6.05 after sterilization . ( 2 ) Solution 2 ...
386. lappuse
... potassium bro- mide ( infrared spectrophotometric quality ) . For a 0.5 percent potassium bromide mixture , use 1 milligram of sample . For a 0.25 percent potassium bromide mixture , use 0.5 milligram of sample . A mortar and pestle , a ...
... potassium bro- mide ( infrared spectrophotometric quality ) . For a 0.5 percent potassium bromide mixture , use 1 milligram of sample . For a 0.25 percent potassium bromide mixture , use 0.5 milligram of sample . A mortar and pestle , a ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning